Sonia Wolf

Dr. Sonia Wolf serves as an Honorary Clinical Senior Lecturer at the Blizard Institute within Queen Mary University of London's Faculty of Medicine and Dentistry. She holds a joint Consultant position between NHS Blood and Transplant (NHSBT) and Barts Health NHS Trust, specializing in sickle cell disease and thalassaemia care while providing national clinical expertise in Red Cell Immunology through NHSBT. Her institutional affiliations extend to the Genomics England Sickle Cell Advisory Board and the National Haemoglobinopathy Panel.

Dr. Wolf's educational background includes:

• MBBS and BSc from Imperial College London
• PhD in adult-T cell leukaemia/lymphoma (Medical Research Council-funded)
• Professional qualifications: MRCP, FRCPath

Her research integrates genomic and immunological methodologies to address critical challenges in haematology, with dual focus on advancing clinical protocols for haemoglobinopathies and confronting systemic inequities in sickle cell disease management. Current initiatives examine plasma exchange for acute chest syndrome and genomic approaches to improve health outcomes in Black populations.

Publication analysis reveals consistent emphasis on translational haematology research, evolving from viral oncology studies toward health equity investigations. Her work demonstrates increasing integration of genomic technologies with clinical practice, particularly in transfusion medicine and sickle cell disease management, while maintaining critical examination of healthcare delivery disparities.

Key recognitions include:

• British Society of Haematology Crucible prize for research on systemic racism in sickle cell care
• European Society of Haematology Clinical Research Training award for plasma exchange innovation

Dr. Wolf actively mentors Masters' students at University of Greenwich and Imperial College London while securing competitive funding including MRC Clinical Research Training Fellowships and Genomics England sub-PI roles. Her grant portfolio prioritizes clinical translation and health equity initiatives.

She co-authors NHSBT national reports, directs red cell genotyping program expansion across four specialist haemoglobinopathy centres, and contributes to monthly National Haemoglobinopathy Panel case reviews for complex patient management.